Novo Nordisk A/S (NVO)
47.60
-0.17
(-0.36%)
USD |
NYSE |
Dec 18, 16:00
47.54
-0.06
(-0.13%)
After-Hours: 20:00
Novo Nordisk Accounts Payable (Quarterly): 3.763B for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Evaxion AS | -- |
| Ascendis Pharma A/S | 92.36M |
| Regeneron Pharmaceuticals, Inc. | 903.80M |
| Omeros Corp. | 12.50M |
| Viking Therapeutics, Inc. | 4.413M |